11-110430242-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000260270.3(FDX1):āc.122G>Cā(p.Arg41Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000756 in 1,205,422 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000260270.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX1 | NM_004109.5 | c.122G>C | p.Arg41Pro | missense_variant | 1/4 | ENST00000260270.3 | NP_004100.1 | |
FDX1 | XM_047426566.1 | c.8+889G>C | intron_variant | XP_047282522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX1 | ENST00000260270.3 | c.122G>C | p.Arg41Pro | missense_variant | 1/4 | 1 | NM_004109.5 | ENSP00000260270 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000555 AC: 84AN: 151416Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000785 AC: 827AN: 1053898Hom.: 4 Cov.: 30 AF XY: 0.000780 AC XY: 388AN XY: 497542
GnomAD4 genome AF: 0.000554 AC: 84AN: 151524Hom.: 0 Cov.: 32 AF XY: 0.000594 AC XY: 44AN XY: 74052
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2021 | The c.122G>C (p.R41P) alteration is located in exon 1 (coding exon 1) of the FDX1 gene. This alteration results from a G to C substitution at nucleotide position 122, causing the arginine (R) at amino acid position 41 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at